SCHEMBL14155122

SCHEMBL14155122

CC(C)(CC(C)(C)n1ncc2ccccc21)NO

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ NPC1 O15118 4/20 0.36
▸ RAB9A P51151 4/20 0.36
▸ RECQL P46063 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ KMO O15229 1/20 0.36
▸ ASAH1 Q13510 2/20 0.36
▸ TSHR P16473 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ POLB P06746 4/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ ELANE P08246 1/20 0.33
▸ CNR2 P34972 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14155125 0.81 KMO (0.46) CYP11B1CYP11B2SMN1; SMN2KMT2AKMO
SCHEMBL14155126 0.81 CYP11B1 (0.43) CYP11B1CYP11B2
SCHEMBL19738739 0.78 RECQL (0.42) CYP11B1CYP11B2NPC1RAB9ARECQL
SCHEMBL19684424 0.75 SLC6A2 (0.40) CYP11B1CYP11B2NPC1RAB9ARECQL
SCHEMBL10050859 0.73 RECQL (0.43) CYP11B1CYP11B2NPC1RAB9ARECQL
SCHEMBL30449976 0.73 RECQL (0.43) CYP11B1CYP11B2NPC1RAB9ARECQL
SCHEMBL28172026 0.72 CYP11B1 (0.42) CYP11B1CYP11B2NPC1RAB9ARECQL
SCHEMBL22559859 0.69 RECQL (0.40) CYP11B1CYP11B2NPC1RAB9ARECQL
SCHEMBL5305834 0.68 CYP11B1 (0.43) CYP11B1CYP11B2NPC1RAB9ARECQL
SCHEMBL29520927 0.67 RECQL (0.43) CYP11B1CYP11B2RAB9ARECQLSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1827427-B1 ARYLOXYETHYLAMINE DERIVATIVES WITH A COMBINATION OF PARTIAL DOPAMINE-D2 RECEPTOR AGONISM AND SEROTONIN REUPTAKE INHIBITION SOLVAY PHARM BV (NL) 2008-07-23 — — EP disclosed
Send feedback